Amantadine may reverse punding in Parkinson's disease - Observation in a patient

Movement Disorders

Volumn 23, Issue 1, 2008, Pages 129-130

  Kashihara, Kenichi ^a   Imamura, Takaki ^a  

^a OKAYAMA KYOKUTO HOSPITAL   (Japan)

Author keywords

Amantadine; Parkinson's disease; Punding; Stereotypy; Treatment

Indexed keywords

AMANTADINE; BROMOCRIPTINE; DECARBOXYLASE INHIBITOR; LEVODOPA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PERGOLIDE; QUETIAPINE; SELEGILINE;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DISEASE COURSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MECHANISM; DRUG WITHDRAWAL; FEMALE; HUMAN; MINI MENTAL STATE EXAMINATION; MOTOR PERFORMANCE; OUTCOME ASSESSMENT; PARKINSON DISEASE; PRIORITY JOURNAL;

AGED; AMANTADINE; DOPAMINE AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; PARKINSON DISEASE; STEREOTYPIC MOVEMENT DISORDER;

EID: 39549090175     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21780     Document Type: Article

References (10)

1. Rylander G. Psychoses and the punding and choreiform syndrome in addiction to central stimulant drugs. Psychiatr Neurol Neurochir 1972;75:203-212.
2. Fernandez HH, Friedman JH. Punding on L-dopa. Mov Disord 1999;14:836-838.
3. Evans AH, Katzenschlager R, Paviour D, O'Sullivan JD, Appel S, Lawrence AD, Lees AJ. Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Mov Disord 2004;19:397-405.
4. Silveira-Moriyama L, Evans AH, Katzenschlager R, Lees AJ. Punding and dyskinesias. Mov Disord 2006;21:2214-2217.
5. Metman LV, Del Dotto P, van den Munckhof P, Fang J, Mouradian MM, Chase TN. Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease. Neurology 1998;50:1323-1326.
6. Alexander GE, Crutcher MD, DeLong MR. Basal gangliathalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog Brain Res 1990;85:119-146.
7. Calon F, Rajiput AH, Hornykiewicz O, Bedard PJ, Di Paolo T. Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease. Neurobiol Dis 2003;14:404-416.
8. Graybiel AM, Canales JJ, Capper-Loup C. Levodopa-induced dyskinesias and dopamine-dependent stereotypies: a new hypothesis. Trends Neurosci 2000;23 (Suppl):S71-S77.
9. Gerfen CR. The neostriatal mosaic: compartmentalization of corticostriatal input and striatonigral output systems. Nature 1984;311:461-464.
10. Saka E, Goodrich C, Harlan P, Madras BK, Graybiel AM. Repetitive behaviors in monkeys are linked to specific striatal activation patterns. J Neurosci 2004;24:7557-7565.